08:19:45 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



V:CZO - Ceapro Inc. - http://www.ceapro.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CZO - V  5.00.25·0.2610.00.26+0.028.392.022210.245  0.26  0.240.64  0.1515:08:52Mar 2815 min RT 2¢
TSX-V - V5.00.25·0.2610.00.26+0.028.372.01790.245  0.26  0.240.64  0.1515:08:5215 min
NEO ATS - U 0.25+0.014.23.0150.25  0.25  0.2512:53:5215 min
Omega - O 0.25+0.014.23.0110.25  0.25  0.2512:51:2615 min
CX2 - H 0.26+0.028.314.0360.25  0.26  0.2514:23:5415 min

Recent Trades - Last 10 of 21
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:08:52V0.260.025007 TD Sec33 CanaccordK
15:08:52V0.260.025007 TD Sec7 TD SecK
14:30:48V0.260.024,00085 Scotia33 CanaccordK
14:30:48V0.260.022,00085 Scotia1 AnonymousK
14:23:54V0.260.023,0001 Anonymous1 AnonymousK
14:23:54H0.260.021,00057 Interactive1 AnonymousK
12:53:52U0.250.011,00085 Scotia2 RBCK
12:53:52U0.250.0150085 Scotia2 RBCK
12:53:52V0.250.017,50085 Scotia2 RBCK
12:51:27H0.250.011,50085 Scotia1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-03-28 11:36C:CZO0.235News ReleaseCeapro, Aeterna merger receives court approval
2024-03-12 14:33C:CZO0.23News ReleaseCeapro, Aeterna holders OK merger at March 3 meeting
2024-02-26 12:40C:CZO0.26News ReleaseAeterna, Ceapro receive proxy support for merger
2024-02-23 11:36C:CZO0.26News ReleaseCeapro talks Aeterna merger, operations update
2024-02-15 18:15C:CZO0.18News ReleaseCeapro mails information circular for March 12 meeting
2023-12-14 10:31C:CZO0.225Resume TradingCeapro to resume at 8 a.m. PT
2023-12-14 09:27C:CZO0.225News ReleaseAeterna Zentaris, Ceapro sign definitive merger deal
2023-12-14 07:57C:CZO0.225Halt TradingCeapro halted at the open
2023-12-13 13:21C:CZO0.23News ReleaseCeapro begins patient dosing in avenanthramides study
2023-11-29 14:59C:CZO0.24News ReleaseCeapro loses $1.04-million in Q3 2023
2023-11-29 09:03C:CZO0.25SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-29 09:03C:CZO0.25SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-27 11:01C:CZO0.25News ReleaseCeapro begins study of avenanthramides for inflammation
2023-11-07 11:25C:CZO0.305News ReleaseCeapro, Natex to work on PGX tech development
2023-08-29 15:27C:CZONews ReleaseCeapro loses $1.15-million in Q2
2023-08-29 08:35C:CZO0.40SEDAR Interim MD & ASEDAR Interim MD & A
2023-08-29 08:01C:CZO0.40SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-25 09:38C:CZO0.44News ReleaseCeapro extends supply, distribution deal with Symrise
2023-07-18 15:30C:CZO0.43News ReleaseCeapro expands research work with Angiogenesis
2023-06-07 12:56C:CZO0.47News ReleaseCeapro shareholders approve all matters at AGSM